About
Genpharmasec Limited buys, sells, and distributes pharmaceutical activities and services in India. The company operates through two segments, Diagnostic Pharma Equipment, and Investment and Trading in Securities. The Diagnostic Pharma Equipment segment distributes state-of-the-art diagnostic equipment comprising of i-STAT analyzers and its cartridges used to analyze blood for test results in Intensive Care Units (ICUs) of hospitals. The Investment and Trading in Securities segment operates in secondary securities market. The company was formerly known as Generic Pharmasec Limited and changed its name to Genpharmasec Limited in October 2021. Genpharmasec Limited was incorporated in 1992 and is based in Mumbai, India.
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49.71 | 55.43 | 39.83 | 32.64 | 12.04 | 14.01 | 8.48 | 6.03 | 5.20 | 10.20 | 6.38 | 7.86 | 6.22 |
| Expenses | 48.75 | 53.44 | 41.07 | 33.10 | 11.10 | 15.01 | 7.76 | 5.90 | 5.00 | 10.21 | 6.37 | 7.89 | 6.01 |
| Operating Profit | 0.96 | 1.99 | -1.24 | -0.46 | 0.94 | -1.00 | 0.72 | 0.13 | 0.20 | -0.01 | 0.01 | -0.03 | 0.21 |
| OPM % | 1.93 | 3.59 | -3.11 | -1.41 | 7.81 | -7.14 | 8.49 | 2.16 | 3.85 | -0.10 | 0.16 | -0.38 | 3.38 |
| Other Income | 0.37 | 1.02 | 0.98 | 0.46 | 0.69 | 0.94 | 0.81 | 0.75 | 0.57 | 0.31 | 0.14 | 0.15 | 0.06 |
| Depreciation | 0.67 | 0.68 | 0.67 | 0.56 | 0.27 | 0.26 | 0.10 | 0.30 | 0.16 | 0.03 | 0.12 | 0.00 | 0.01 |
| Interest | 0.40 | 0.48 | 0.41 | 0.23 | 0.12 | 0.11 | 0.16 | 0.07 | 0.10 | 0.16 | 0.00 | 0.07 | 0.06 |
| Profit before tax | 0.26 | 1.85 | -1.34 | -0.79 | 1.24 | -0.43 | 1.27 | 0.51 | 0.51 | 0.11 | 0.03 | 0.05 | 0.20 |
| Tax % | 165.38 | 27.03 | -37.31 | 48.10 | 2.42 | -37.21 | 40.16 | -39.22 | 35.29 | 345.45 | -100.00 | 80.00 | -420.00 |
| Net Profit | -0.17 | 1.36 | -0.83 | -1.18 | 1.22 | -0.27 | 0.76 | 0.70 | 0.33 | -0.27 | 0.06 | 0.01 | 1.05 |
| EPS in Rs | 0.00 | 0.03 | -0.01 | -0.02 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Sales | 140.00 | 34.00 | 30.00 | 26.00 |
| Expenses | 139.00 | 33.00 | 30.00 | 25.00 |
| Operating Profit | 1.00 | 0.00 | 0.00 | 0.00 |
| OPM % | 0.90 | 0.20 | 0.10 | 1.00 |
| Other Income | 3.00 | 3.00 | 1.00 | 0.00 |
| Interest | 1.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 2.00 | 1.00 | 0.00 | 0.00 |
| Profit before tax | 1.00 | 2.00 | 0.00 | 0.00 |
| Tax % | 42.00 | 35.00 | 168.00 | -300.00 |
| Net Profit | 1.00 | 1.00 | 0.00 | 1.00 |
| EPS in Rs | 0.03 | 0.02 | 0.00 | 0.02 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Equity Capital | 55.00 | 55.00 | 55.00 | 28.00 |
| Reserves | 11.00 | 10.00 | 9.00 | -12.00 |
| Borrowings | 35.00 | 5.00 | 4.00 | 3.00 |
| Other Liabilities | 37.00 | 9.00 | 3.00 | 1.00 |
| Total Liabilities | 138.00 | 80.00 | 71.00 | 20.00 |
| Fixed Assets | 41.00 | 8.00 | 1.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.00 | 19.00 | 19.00 | 1.00 |
| Other Assets | 95.00 | 53.00 | 51.00 | 19.00 |
| Total Assets | 138.00 | 80.00 | 71.00 | 20.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Cash from Operating Activity | -18.00 | 3.00 | -3.00 | -3.00 |
| Cash from Investing Activity | 13.00 | -15.00 | -28.00 | 0.00 |
| Cash from Financing Activity | 4.00 | -1.00 | 48.00 | 3.00 |
| Net Cash Flow | 0.00 | -14.00 | 17.00 | 0.00 |
| Free Cash Flow | -21.00 | -3.00 | -3.00 | -3.00 |
| CFO/OP % | -1,357.00 | 3,825.00 | -7,275.00 | -1,277.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Debtor Days | 76.00 | 148.00 | 109.00 | 82.00 |
| Inventory Days | 39.00 | 104.00 | 133.00 | 151.00 |
| Days Payable | 90.00 | 105.00 | 36.00 | 21.00 |
| Cash Conversion Cycle | 26.00 | 147.00 | 207.00 | 211.00 |
| Working Capital Days | 61.00 | 133.00 | 213.00 | 199.00 |
| ROCE % | 3.00 | 3.00 | 2.00 | — |
Corporate Actions
4 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 09 Jan 2024 | 09 Jan 2024 | — | — | Right Issue of Equity Shares |
| Other | 25 May 2023 | — | — | — | E.G.M. |
| Split | 11 Apr 2019 | 12 Apr 2019 | 10:1 | — | |
| Other | 03 Aug 2016 | 04 Aug 2016 | — | — | Reduction of Capital |